JPRN-jRCT1031210293招募中未知
Additional exploratory analysis of biomarkers in the PARADIGM Exploratory study in patients with advanced/recurrent colorectal cancer
Contact for Clinical Trial Information0 个研究点目标入组 757 人开始时间: 2021年9月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 757
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •1.Participants enrolled in the PARADIGM Exploratory Study (NCT02394834) who have consented to the secondary use of samples and genomic data and have not withdrawn their consent.
- •2.Participants with sufficient surplus samples for gene expression/mutation and pathomorphologic (IHC, IF and/or ISH, etc.) analysis.
排除标准
- •Participants who are considered inappropriate for participation in this study by the research institution
研究者
相似试验
进行中（未招募）
1 期
Biomarkermoderate-to-severe psoriasisMedDRA version: 19.0 Level: PT Classification code 10037153 Term: Psoriasis System Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2015-002588-40-DEniversity Hospital Schleswig-Holstein40
尚未招募
Unknown
Exploratory research of biomarkers for investigational drugs using tear fluid samplesMeibomian Gland DysfunctionJPRN-UMIN000049186Santen Pharmaceutical Co. Ltd.29
尚未招募
不适用
A retrospective study to explore the biomarkers in lung cancer immunotherapy, 2nd stage -irAE predictionung cancerJPRN-UMIN000051528ational Cancer Center Hospital East350
已完成
不适用
Exploratory study to investigate biomarkers associated with pathogenesis of infantile hemangioma.Infantile hemangiomaJPRN-UMIN000038574Wakayama Medical University45
招募中
不适用
An exploratoly study to evaluate biomarkers in cell free DNA of "Sequential therapy from afatinib to osimertinib for EGFR mutant non small cell lung cancer: a multicenter prospective observational study (Gio Tag Japan)".non-small cell lung cancer(EGFR mutation positive)JPRN-UMIN000043235HANSHIN Oncology Group93